A Study to Determine the Absolute Bioavailability of YH4808 Using Simultaneous Oral Therapeutic- and [14C]-Labeled Intravenous Microdoses

Trial Profile

A Study to Determine the Absolute Bioavailability of YH4808 Using Simultaneous Oral Therapeutic- and [14C]-Labeled Intravenous Microdoses

Completed
Phase of Trial: Phase 0

Latest Information Update: 11 Jun 2014

At a glance

  • Drugs YH 4808 (Primary) ; YH 4808 (Primary)
  • Indications Gastro-oesophageal reflux; NSAID-induced ulcer; Reflux oesophagitis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 17 Apr 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to completed.
    • 25 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top